AKT1 and breast carcinoma: In addition, in a breast cancer (MDA-MB-468) xenograft mouse model study, PS was found to exhibit antiproliferative activity through concentration-dependent inhibition of Akt and upregulation of Bax (Wakimoto et al., 2017).